INNOVATIVE EYEWEAR, INC. Capital Expenditures
INNOVATIVE EYEWEAR, INC. (LUCY) reported Capital Expenditures of $72.51 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $17.03K, a 35.63% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $14.84K.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $40.65K, a 25.85% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $72.51K, a 16.57% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $62.20K, a 20.72% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $78.46K, a 35.45% decline from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $121.56K, a 484.93% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $17.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $31.86K derived: sum of 2 quarters · filed 2026-03-25 | $31.86K derived: sum of 3 quarters · filed 2026-08-14 | $72.51K 10-K · filed 2026-03-25 |
| 2025-09-30 | $14.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $14.84K derived: sum of 2 quarters · filed 2026-08-14 | $55.48K 10-Q · filed 2025-11-13 | $81.94K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $40.65K 10-Q · filed 2026-08-14 | $67.10K derived: sum of 3 quarters · filed 2026-08-14 | $67.10K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $40.65K 10-Q · filed 2026-05-14 | $67.10K derived: sum of 2 quarters · filed 2026-05-14 | $67.10K derived: sum of 3 quarters · filed 2026-05-14 | $70.55K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $26.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $26.45K derived: sum of 2 quarters · filed 2026-03-25 | $29.91K derived: sum of 3 quarters · filed 2026-03-25 | $62.20K 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.45K derived: sum of 2 quarters · filed 2025-11-13 | $35.75K 10-Q · filed 2025-11-13 | $9.49K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $3.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $35.75K 10-Q · filed 2025-08-14 | $9.49K derived: sum of 3 quarters · filed 2025-08-14 | $79.78K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $32.30K 10-Q · filed 2025-05-13 | $6.04K derived: sum of 2 quarters · filed 2025-05-13 | $76.33K derived: sum of 3 quarters · filed 2025-05-13 | $82.63K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$26.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $44.03K derived: sum of 2 quarters · filed 2025-03-24 | $50.33K derived: sum of 3 quarters · filed 2025-03-24 | $78.46K 10-K · filed 2025-03-24 |
| 2023-09-30 | $70.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $76.59K derived: sum of 2 quarters · filed 2024-11-12 | $104.72K 10-Q · filed 2024-11-12 | $135.72K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $6.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $34.44K 10-Q · filed 2024-08-12 | $65.43K derived: sum of 3 quarters · filed 2024-08-12 | $115.60K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $28.14K 10-Q · filed 2024-05-14 | $59.13K derived: sum of 2 quarters · filed 2024-05-14 | $109.30K derived: sum of 3 quarters · filed 2024-05-14 | $117.59K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $81.17K derived: sum of 2 quarters · filed 2024-03-25 | $89.45K derived: sum of 3 quarters · filed 2024-03-25 | $121.56K 10-K · filed 2024-03-25 |
| 2022-09-30 | $50.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $58.46K derived: sum of 2 quarters · filed 2023-11-14 | $90.56K 10-Q · filed 2023-11-14 | $100.68K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $8.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $40.39K 10-Q · filed 2023-08-11 | $50.51K derived: sum of 3 quarters · filed 2023-08-11 | $59.14K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $32.11K 10-Q · filed 2023-05-12 | $42.23K derived: sum of 2 quarters · filed 2023-05-12 | $50.85K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $10.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $18.75K derived: sum of 2 quarters · filed 2023-03-24 | $20.78K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $8.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $10.66K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $2.04K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |